Indian pharmaceuticals sector likely to log revenue growth of 8-10% in FY25: CRISIL

CRISIL Ratings in its latest report has said that the Indian pharmaceuticals sector is likely to log a revenue growth of 8-10% this fiscal (FY25), after around 10% growth last year, supported by healthy exports to regulated markets, recovery in exports to semi-regulated markets and steady domestic demand. The resultant improvement in operating leverage along … Read more

India becomes 6th largest market in global MSCI IMI index, surpasses China

In yet another feat to India’s growing clout in the world economy, the country has become the sixth-largest market in the MSCI All Country World Investable Market Index (ACWI IMI), surpassing China.  The global index tracks capital market performance across the world. The index includes large- and mid-cap stocks and is a more inclusive version … Read more

US Fed rate cut to boost investment and business sentiment, all eyes on India

The softening of US Fed rate by 0.5 percentage point (50 bps) is a welcome step, given the strengthening US economy with stable inflation, industry analysts said on Thursday, as the focus turns to India which is the fastest-growing economy in the world.  After the rate cut decision, the US dollar turned higher, putting pressure … Read more